ENB Therapeutics

New York, United States

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

Jan 2022

Series A

Biotechnology Medical Therapeutics

Top Investors

BioAdvanceAlexandria Venture InvestmentsRemiges VenturesNew York VenturesAvestria Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ENB Therapeutics

Who are ENB Therapeutics's investors?

ENB Therapeutics's investors include BioAdvance, Alexandria Venture Investments, Remiges Ventures, New York Ventures, Avestria Ventures.

Where is ENB Therapeutics headquartered?

ENB Therapeutics is headquartered in New York, United States.

What does ENB Therapeutics do?

ENB Therapeutics develops therapies to break barriers that prevent the majority of patients from responding to immunotherapy agents.

What stage is ENB Therapeutics at?

ENB Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 3, 2022.

MLA

"ENB Therapeutics — Funding & Investors." VCBacked, January 3, 2022, https://www.vcbacked.co/company/enb-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). ENB Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/enb-therapeutics

Wikipedia (cite web)

{{cite web |title=ENB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/enb-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 3, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.